Sergio Pecorelli, MD
Professor (Adjunct) of Obstetrics, Gynecology, and Reproductive Sciences
Research & Publications
Biography
News
Coauthors
Selected Publications
- Letter to the Editor: 2023 FIGO staging system for endometrial cancerRaspagliesi F, Creasman W, Bogani G, Pecorelli S. Letter to the Editor: 2023 FIGO staging system for endometrial cancer. International Journal Of Gynecology & Obstetrics 2023, 164: 366-368. PMID: 38055222, DOI: 10.1002/ijgo.15266.
- COVID-19 vaccine literacy: A scoping reviewBiasio L, Zanobini P, Lorini C, Monaci P, Fanfani A, Gallinoro V, Cerini G, Albora G, Del Riccio M, Pecorelli S, Bonaccorsi G. COVID-19 vaccine literacy: A scoping review. Human Vaccines & Immunotherapeutics 2023, 19: 2176083. PMID: 36794338, PMCID: PMC10026896, DOI: 10.1080/21645515.2023.2176083.
- Italian Adults’ Likelihood of Getting COVID-19 Vaccine: A Second Online SurveyBiasio L, Bonaccorsi G, Lorini C, Mazzini D, Pecorelli S. Italian Adults’ Likelihood of Getting COVID-19 Vaccine: A Second Online Survey. Vaccines 2021, 9: 268. PMID: 33802873, PMCID: PMC8002675, DOI: 10.3390/vaccines9030268.
- Assessing COVID-19 vaccine literacy: a preliminary online surveyBiasio L, Bonaccorsi G, Lorini C, Pecorelli S. Assessing COVID-19 vaccine literacy: a preliminary online survey. Human Vaccines & Immunotherapeutics 2020, 17: 1304-1312. PMID: 33118868, PMCID: PMC8078752, DOI: 10.1080/21645515.2020.1829315.
- Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Beller U, Quinn M, Benedet J, Creasman W, Ngan H, Maisonneuve P, Pecorelli S, Odicino F, Heintz A. Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s7-27. PMID: 17161169, DOI: 10.1016/s0020-7292(06)60028-3.
- Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Beller U, Benedet J, Creasman W, Ngan H, Quinn M, Maisonneuve P, Pecorelli S, Odicino F, Heintz A. Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s29-42. PMID: 17161165, DOI: 10.1016/s0020-7292(06)60029-5.
- Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Quinn M, Benedet J, Odicino F, Maisonneuve P, Beller U, Creasman W, Heintz A, Ngan H, Pecorelli S. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s43-103. PMID: 17161167, DOI: 10.1016/s0020-7292(06)60030-1.
- Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Creasman W, Odicino F, Maisonneuve P, Quinn M, Beller U, Benedet J, Heintz A, Ngan H, Pecorelli S. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s105-43. PMID: 17161155, DOI: 10.1016/s0020-7292(06)60031-3.
- Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Heintz A, Odicino F, Maisonneuve P, Quinn M, Benedet J, Creasman W, Ngan H, Pecorelli S, Beller U. Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s145-60. PMID: 17161156, DOI: 10.1016/s0020-7292(06)60032-5.
- Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Ngan H, Odicino F, Maisonneuve P, Creasman W, Beller U, Quinn M, Heintz A, Pecorelli S, Benedet J. Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s193-203. PMID: 17161158, DOI: 10.1016/s0020-7292(06)60034-9.
- Why Cancer Staging?BENEDET J, PECORELLI S. Why Cancer Staging? International Journal Of Gynecology & Obstetrics 2006, 95: s3-s3. PMID: 29644672, DOI: 10.1016/s0020-7292(06)60026-x.
- Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Heintz A, Odicino F, Maisonneuve P, Quinn M, Benedet J, Creasman W, Ngan H, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s161-92. PMID: 17161157, DOI: 10.1016/s0020-7292(06)60033-7.
- 0009: Extending the Platinum-Free Interval (PFI) with a Non-Platinum Therapy in Platinum (P)-Sensitive Recurrent Ovarian Cancer (Oc): Results From the Socrates Retrospective StudyOdicino F, Katsaros D, Pignata S, Scambia G, Cormio G, Stellato G, Scollo P, Costa B, Magni G, Iaffaioli R, Pecorelli S. 0009: Extending the Platinum-Free Interval (PFI) with a Non-Platinum Therapy in Platinum (P)-Sensitive Recurrent Ovarian Cancer (Oc): Results From the Socrates Retrospective Study. International Journal Of Gynecological Cancer 2006, 16: 601.3-601. DOI: 10.1136/ijgc-00009577-200610001-00009.
- 0047: Claudin-3 and Claudin-4 Receptor Overexpression: Novel Targets for a Type Specific Therapy Against Uterine Serous Papillary Carcinomas Using Clostridium Perfringens EnterotoxinSantin A, Bandiera E, Comper F, Bellone M, Marizzoni S, Zanolini A, Palmieri M, Siegel E, Mckinney J, Thomas M, Hennings L, Roman J, Burnett A, Cannon M, Pecorelli S. 0047: Claudin-3 and Claudin-4 Receptor Overexpression: Novel Targets for a Type Specific Therapy Against Uterine Serous Papillary Carcinomas Using Clostridium Perfringens Enterotoxin. International Journal Of Gynecological Cancer 2006, 16: 612.2-612. DOI: 10.1136/ijgc-00009577-200610001-00047.
- 0178: Oral Gimatecan in Women with Progressing or Recurring Advanced Epithelial Ovarian, Fallopian Tube and Peritoneal CancersPecorelli S, Ray-Coquard I, Colombo N, Parma G, Tognon G, Katsaros D, Lhomme C, Lissoni A, Vermorken J, Du Bois A, Poveda A, Frigerio L, Guastalla J. 0178: Oral Gimatecan in Women with Progressing or Recurring Advanced Epithelial Ovarian, Fallopian Tube and Peritoneal Cancers. International Journal Of Gynecological Cancer 2006, 16: 650.1-650. DOI: 10.1136/ijgc-00009577-200610001-00178.
- 00099 THE SURVIVAL BENEFIT OF INTERVAL DEBULKING SURGERY (IDS) IN ADVANCED OVARIAN CANCER IS MAINTAINED DURING TEN YEARS; THE EORTC GCG 55865 STUDYvan der Burg M, Coens C, van Lent M, Kobierska A, Colombo N, Favalli G, Lacava A, Theodorovic I, Pecorelli S. 00099 THE SURVIVAL BENEFIT OF INTERVAL DEBULKING SURGERY (IDS) IN ADVANCED OVARIAN CANCER IS MAINTAINED DURING TEN YEARS; THE EORTC GCG 55865 STUDY. International Journal Of Gynecological Cancer 2005, 15: 79.1-79. DOI: 10.1136/ijgc-00009577-200509001-00099.
- 00086 ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMASBignotti E, Tassi R, Calza S, Ravaggi A, Romani C, Rossi E, Donzelli C, Falchetti M, Pasinetti B, Odicino F, Pecorelli S, Santin A. 00086 ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMAS. International Journal Of Gynecological Cancer 2005, 15: 75.2-75. DOI: 10.1136/ijgc-00009577-200509001-00086.
- GENE EXPRESSION FINGERPRINT OF UTERINE SEROUS PAPILLARY CARCINOMA: IDENTIFICATION OF NOVEL MOLECULAR MARKERS FOR UTERINE SEROUS CANCER DIAGNOSIS AND THERAPYSantin A, Bellone S, Cane' S, Palmieri M, Bignotti E, Anfossi S, Thomas M, Roman J, Kay H, Burnett A, O'Brien T, Cannon M, John S, Zhan F, Tian E, Pecorelli S. GENE EXPRESSION FINGERPRINT OF UTERINE SEROUS PAPILLARY CARCINOMA: IDENTIFICATION OF NOVEL MOLECULAR MARKERS FOR UTERINE SEROUS CANCER DIAGNOSIS AND THERAPY. International Journal Of Gynecological Cancer 2004, 14: 2.3-2. DOI: 10.1136/ijgc-00009577-200409001-00006.
- AFTER TEN YEARS FOLLOW-UP INTERVAL DEBULKING SURGERY REMAINS A SIGNIFICANT PROGNOSTIC FACTOR FOR SURVIVAL AND PROGRESSION FREE SURVIVAL FOR ADVANCED OVARIAN CANCER: THE EORTC GYNAECOLOGICAL CANCER GROUP STUDYvan der Burg M, Coens C, van Lent M, Kobierska A, Colombo N, Favalli G, Lacave A, Nardi M, Teodorovic I, van Luijk I, Pecorelli S. AFTER TEN YEARS FOLLOW-UP INTERVAL DEBULKING SURGERY REMAINS A SIGNIFICANT PROGNOSTIC FACTOR FOR SURVIVAL AND PROGRESSION FREE SURVIVAL FOR ADVANCED OVARIAN CANCER: THE EORTC GYNAECOLOGICAL CANCER GROUP STUDY. International Journal Of Gynecological Cancer 2004, 14: 3.2-3. DOI: 10.1136/ijgc-00009577-200409001-00008.
- PROGNOSTIC VALUE OF SERUM CA125 AND MARKER HALF-LIFE (T½) FOR LONG-TERM PROGRESSION FREE AND OVERALL SURVIVAL AND OPTIMAL INTERVAL DEBULKING SURGERY (IDS) IN ADVANCED OVARIAN CARCINOMA. A EORTC-GCG STUDYvan Luijk I, Coens C, Kobierska A, Colombo N, Favalli G, Lacave A, Nardi M, Pecorelli S, Teodorovic I, van der Burg M. PROGNOSTIC VALUE OF SERUM CA125 AND MARKER HALF-LIFE (T½) FOR LONG-TERM PROGRESSION FREE AND OVERALL SURVIVAL AND OPTIMAL INTERVAL DEBULKING SURGERY (IDS) IN ADVANCED OVARIAN CARCINOMA. A EORTC-GCG STUDY. International Journal Of Gynecological Cancer 2004, 14: 18.3-19. DOI: 10.1136/ijgc-00009577-200409001-00060.
- Early stage ovarian cancer: the Italian contribution to clinical research. An updateFavalli G, Odicino F, TORRI V, Pecorelli S. Early stage ovarian cancer: the Italian contribution to clinical research. An update. International Journal Of Gynecological Cancer 2001, 11: 12-19. DOI: 10.1136/ijgc-00009577-200107001-00004.
- Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells.Santin A, Bellone S, Ravaggi A, Pecorelli S, Cannon M, Parham G. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Obstetrics And Gynecology 2000, 96: 422-30. PMID: 10960637, DOI: 10.1016/s0029-7844(00)00916-9.
- Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix.Santin A, Hermonat P, Ravaggi A, Pecorelli S, Cannon M, Parham G. Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Obstetrics And Gynecology 1999, 94: 78-82. PMID: 10389722, DOI: 10.1016/s0029-7844(99)00282-3.
- The role of intervention debulking surgery in advanced epithelial ovarian cancer: an EORTC Gynecological Cancer Cooperative Group studyVan Der Burg M, Van Lent M, Buyse M, Kobierska A, Maggioni A, Favalli G, Lacave A, Nardi M, Renard J, Pecorelli S. The role of intervention debulking surgery in advanced epithelial ovarian cancer: an EORTC Gynecological Cancer Cooperative Group study. International Journal Of Gynecological Cancer 1996, 6: 30-38. DOI: 10.1136/ijgc-00009577-199609001-00007.